News & Presentations Filter by Category All 96 Company News 37 Media 22 Newsletter 8 Presentations & Webinars 31 Company News, All Michelle Long 12/11/25 Company News, All Michelle Long 12/11/25 Arovella appoints former CSL CSO Dr Andrew Nash as Non-executive Director Read More Company News, All Michelle Long 5/11/25 Company News, All Michelle Long 5/11/25 ALA exercises Option for Baylor College of Medicine assets Read More Company News, All Michelle Long 30/10/25 Company News, All Michelle Long 30/10/25 AGM 2025 presentation and results Read More Company News, All Michelle Long 29/10/25 Company News, All Michelle Long 29/10/25 Arovella progresses ALA-101 program with appointment of phase 1 CRO Read More Company News, All Michelle Long 28/10/25 Company News, All Michelle Long 28/10/25 Positive FDA Type D Meeting Outcome Read More Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 CLDN18.2 CAR-T cells eliminate pancreatic cancer cells Read More Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 Notice of Annual General Meeting | Thursday 30 October 2025, 11:00 am AEDT Read More Company News, All Bradley Cocks 23/9/25 Company News, All Bradley Cocks 23/9/25 Arovella Receives R&D Tax Rebate of $3,210,000 Read More Company News, All Michelle Long 28/8/25 Company News, All Michelle Long 28/8/25 US Patent to be granted for iNKT Cell Therapy Platform Read More Company News, Presentations & Webinars, All Michelle Long 8/5/25 Company News, Presentations & Webinars, All Michelle Long 8/5/25 EGM presentation and results Read More Company News, All Michelle Long 5/5/25 Company News, All Michelle Long 5/5/25 ALA exclusive iNKT technology option with Baylor Read More Company News, All Michelle Long 15/4/25 Company News, All Michelle Long 15/4/25 Redkite Heartbreak to Hope Walk Read More Company News, All Michelle Long 14/4/25 Company News, All Michelle Long 14/4/25 Extraordinary General Meeting (2025 EGM) Read More Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Research Agreement with University of North Carolina Read More Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Letter from Managing Director and CEO Read More Company News, All Michelle Long 26/2/25 Company News, All Michelle Long 26/2/25 Arovella fully funded to complete phase 1 enrolement and generate clinical data with $15 placement Read More Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More Company News, All Michelle Long 18/11/24 Company News, All Michelle Long 18/11/24 AGM 2024 presentation and results Read More Company News, All Michelle Long 28/10/24 Company News, All Michelle Long 28/10/24 Arovella receives R&D tax rebate of $3.0 million with a further $0.3 million expected Read More Company News, All Michelle Long 14/10/24 Company News, All Michelle Long 14/10/24 Clinical Advisory Board established Read More Older Posts
Company News, All Michelle Long 12/11/25 Company News, All Michelle Long 12/11/25 Arovella appoints former CSL CSO Dr Andrew Nash as Non-executive Director Read More
Company News, All Michelle Long 5/11/25 Company News, All Michelle Long 5/11/25 ALA exercises Option for Baylor College of Medicine assets Read More
Company News, All Michelle Long 30/10/25 Company News, All Michelle Long 30/10/25 AGM 2025 presentation and results Read More
Company News, All Michelle Long 29/10/25 Company News, All Michelle Long 29/10/25 Arovella progresses ALA-101 program with appointment of phase 1 CRO Read More
Company News, All Michelle Long 28/10/25 Company News, All Michelle Long 28/10/25 Positive FDA Type D Meeting Outcome Read More
Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 CLDN18.2 CAR-T cells eliminate pancreatic cancer cells Read More
Company News, All Bradley Cocks 2/10/25 Company News, All Bradley Cocks 2/10/25 Notice of Annual General Meeting | Thursday 30 October 2025, 11:00 am AEDT Read More
Company News, All Bradley Cocks 23/9/25 Company News, All Bradley Cocks 23/9/25 Arovella Receives R&D Tax Rebate of $3,210,000 Read More
Company News, All Michelle Long 28/8/25 Company News, All Michelle Long 28/8/25 US Patent to be granted for iNKT Cell Therapy Platform Read More
Company News, Presentations & Webinars, All Michelle Long 8/5/25 Company News, Presentations & Webinars, All Michelle Long 8/5/25 EGM presentation and results Read More
Company News, All Michelle Long 5/5/25 Company News, All Michelle Long 5/5/25 ALA exclusive iNKT technology option with Baylor Read More
Company News, All Michelle Long 15/4/25 Company News, All Michelle Long 15/4/25 Redkite Heartbreak to Hope Walk Read More
Company News, All Michelle Long 14/4/25 Company News, All Michelle Long 14/4/25 Extraordinary General Meeting (2025 EGM) Read More
Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Research Agreement with University of North Carolina Read More
Company News, All Michelle Long 3/3/25 Company News, All Michelle Long 3/3/25 Letter from Managing Director and CEO Read More
Company News, All Michelle Long 26/2/25 Company News, All Michelle Long 26/2/25 Arovella fully funded to complete phase 1 enrolement and generate clinical data with $15 placement Read More
Company News, All Michelle Long 10/1/25 Company News, All Michelle Long 10/1/25 Arovella fully funded to complete phase 1 with $20m placement Read More
Company News, All Michelle Long 18/11/24 Company News, All Michelle Long 18/11/24 AGM 2024 presentation and results Read More
Company News, All Michelle Long 28/10/24 Company News, All Michelle Long 28/10/24 Arovella receives R&D tax rebate of $3.0 million with a further $0.3 million expected Read More
Company News, All Michelle Long 14/10/24 Company News, All Michelle Long 14/10/24 Clinical Advisory Board established Read More
